Revision 1
Cell Signaling Technology

Orders: 877-616-CELL (2355) [email protected]

Support: 877-678-TECH (8324)

Web: [email protected] cellsignal.com

3 Trask LaneDanversMassachusetts01923USA
For Research Use Only. Not for Use in Diagnostic Procedures.
Kit Includes* Quantity Applications Dilution Isotype
Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP™ Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-MAPKAPK-2 (Thr334) (27B7) Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-HSP27 (Ser82) Antibody II 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-SAPK/JNK (Thr183/Tyr185) (G9) Mouse mAb 140 µl HCA, ICW, IF-IC 1:10 Mouse IgG1
Phospho-c-Jun (Ser73) (D47G9) XP™ Rabbit mAb 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Phospho-p53 (Ser15) (16G8) Mouse mAb 140 µl HCA, ICW, IF-IC 1:10 Mouse IgG1
Cleaved Caspase-3 (Asp175) Antibody 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG
Cleaved PARP (Asp214) Antibody (Human Specific) 140 µl HCA, ICW, IF-IC 1:10 Rabbit IgG

*Component formulation specific to kit.

Applications Key: HCA=High Content Analysis, ICW=In-Cell Western, IF-IC=Immunofluorescence (Immunocytochemistry)

Description

CST’s PathScan® Multi-Target HCA Stress and Apoptosis Kit contains eight primary antibodies that target cellular stress and apoptotic signaling pathways. This kit is designed to elucidate the signaling occurring through key pathway nodes using automated imaging or laser scanning platforms or manual immunofluorescent microscopy. The kit provides the investigator with a quick and easy means to choose the endpoints that will be the most robust and useful for subsequent studies, whether large high content/high throughput screening projects or single small-scale experiments. The antibodies are supplied at 10X of their optimal dilution for immunofluorescent applications. This allows the antibodies to be easily diluted to their 1X working concentrations and dispensed into multi-well plates or slides. 140 μl of each antibody is supplied, which is sufficient for 24 wells on 96-well plates (50 μl 1X per well) or one row on two 96-well plates.

Storage

Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

Background

Cellular stress and apoptosis involve a complex network of signaling pathways that maintain cellular homeostasis when confronted with a variety of potentially damaging effectors, including UV and gamma radiation, chemotherapeutic agents, osmotic shock, inflammatory cytokines, and other environmental stresses. The manner in which cells respond to stress has become an important metric in the study of disease due to the potential deregulation of these pathways in disease states. For example, cancer cells can affect these pathways to promote cell growth and metastasis (1). Some of the key members involved in stress-activated signaling belong to the mitogen-activated protein kinase (MAPK) pathway. The stress-activated protein kinase/Jun-amino-terminal kinase (SAPK/JNK) is one such member that is potently and preferentially activated by a variety of environmental stresses (2-7). SAPK/JNK, when active as a dimer, can translocate to the nucleus where it regulates transcription through its effects on transcription factors such as c-Jun (4,6). Activation of c-Jun by phosphorylation at Ser63 and Ser73 through SAPK/JNK affects a diverse array of biological functions including cell proliferation, differentiation, and apoptosis (8). Similar to the SAPK/JNK pathway, p38 MAPK is activated by a variety of cellular stresses (9-13). When phosphorylated at Thr180 and Tyr182, p38 MAPK has been shown to activate MAP kinase-activated protein kinase 2 (MAPKAPK-2) and the transcription factors ATF-2, Max, and MEF2 (11-16). Phosphorylation at Thr222, Ser272, and Thr334 appears to be essential for the activity of MAPKAPK-2 (17), which can result in the phosphorylation of heat shock protein (HSP) 27 at Ser15, Ser78, and Ser82 (9,18). HSP27 is one of the small HSPs that are constitutively expressed at different levels in various cell types and tissues. In response to stress, the expression level of HSP27 increases several-fold to confer cellular resistance to the adverse environmental change (18). The SAPK/JNK and p38 MAPK pathways also contribute to cell cycle checkpoint control through the activation of the p53 tumor suppressor protein, which plays a major role in cellular response to DNA damage and other genomic aberrations (19). Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis (20). Stress-activated pathways also control the transcription of apoptotic proteins and mediators, thereby playing an important role in apoptosis and cell survival. Apoptosis is a regulated cellular suicide mechanism characterized by nuclear condensation, cell shrinkage, membrane blebbing, and DNA fragmentation (21). Cell survival requires the active suppression of apoptosis, which is accomplished by inhibiting the expression of pro-apoptotic factors as well as promoting the expression of anti-apoptotic factors. Caspases, a family of cysteine proteases, are the central regulators of apoptosis. Initiator caspases (including caspase-2, -8, -9, -10, -11, and -12) are closely coupled to pro-apoptotic signals. Once activated, these caspases cleave and activate downstream effector caspases (including caspase-3, -6, and -7), which in turn execute apoptosis by cleaving cellular proteins following specific asparagine residues (1). Caspase-3 is a critical executioner of apoptosis, as it is either partially or totally responsible for the proteolytic cleavage of many key proteins such as the nuclear enzyme poly (ADP-ribose) polymerase (PARP) (22). PARP appears to be involved in DNA repair in response to environmental stress (23). PARP helps cells to maintain their viability; cleavage of PARP facilitates cellular disassembly and serves as a marker of cells undergoing apoptosis (24).

  1. Herr, I. and Debatin, K.M. (2001) Blood 98, 2603-14.
  2. Davis, R.J. (1999) Biochem Soc Symp 64, 1-12.
  3. Ichijo, H. (1999) Oncogene 18, 6087-93.
  4. Kyriakis, J.M. and Avruch, J. (2001) Physiol Rev 81, 807-69.
  5. Kyriakis, J.M. (1999) J Biol Chem 274, 5259-62.
  6. Leppä, S. and Bohmann, D. (1999) Oncogene 18, 6158-62.
  7. Whitmarsh, A.J. and Davis, R.J. (1998) Trends Biochem Sci 23, 481-5.
  8. Davis, R.J. (2000) Cell 103, 239-52.
  9. Rouse, J. et al. (1994) Cell 78, 1027-37.
  10. Han, J. et al. (1994) Science 265, 808-11.
  11. Lee, J.C. et al. Nature 372, 739-46.
  12. Freshney, N.W. et al. (1994) Cell 78, 1039-49.
  13. Raingeaud, J. et al. (1995) J Biol Chem 270, 7420-6.
  14. Zervos, A.S. et al. (1995) Proc Natl Acad Sci U S A 92, 10531-4.
  15. Zhao, M. et al. (1999) Mol Cell Biol 19, 21-30.
  16. Yang, S.H. et al. (1999) Mol Cell Biol 19, 4028-38.
  17. Ben-Levy, R. et al. (1995) EMBO J 14, 5920-30.
  18. Landry, J. et al. (1992) J Biol Chem 267, 794-803.
  19. Reinhardt, H.C. and Yaffe, M.B. (2009) Curr Opin Cell Biol 21, 245-55.
  20. Levine, A.J. (1997) Cell 88, 323-31.
  21. Elmore, S. (2007) Toxicol Pathol 35, 495-516.
  22. Fernandes-Alnemri, T. et al. (1994) J Biol Chem 269, 30761-4.
  23. Satoh, M.S. and Lindahl, T. (1992) Nature 356, 356-8.
  24. Oliver, F.J. et al. (1998) J Biol Chem 273, 33533-9.

Background References

    Trademarks and Patents

    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    PathScan is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit cellsignal.com/trademarks for more information.

    限制使用

    除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。

    专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专

    Revision 1
    #7103

    PathScan® Multi-Target HCA Stress and Apoptosis Kit

    PathScan® Multi-Target HCA Stress and Apoptosis Kit: Image 1 Expand Image
    A549 细胞未经(蓝色)或经 25 μg/ml anisomycin(红色)或 1 μM staurosporine(绿色)处理。测量 PathScan® Multi-Target HCA Stress and Apoptosis Kit 中抗体的平均荧光强度。在 Acumen® HCS 平台上生成数据。
    PathScan® Multi-Target HCA Stress and Apoptosis Kit: Image 2 Expand Image
    PathScan® Multi-Target HCA Stress and Apoptosis Kit 中的抗体的信号转导通路。代表性共聚焦免疫荧光影像显示了未处理(左或上)或处理过(右或下)的细胞中个体蛋白的典型定位。
    PathScan® Multi-Target HCA Stress and Apoptosis Kit: Image 3 Expand Image
    可用于 PathScan® Multi-Target HCA Stress 和 Apoptosis Kit 的 96 孔板布局示意图。在这个通用图上,顺着平板的列进行四种处理,每个样品测试三次,而同时在这八种抗体中,将每种抗体加到 96 孔板的各行中。这种布局设计旨在让研究人员在一个 96 孔板中观察细胞应激和凋亡通路的信号转导。上图是其中一个例子;用户可能希望根据他们的需求重组板图。
    PathScan® Multi-Target HCA Stress and Apoptosis Kit: Image 4 Expand Image
    HeLa 细胞暴露不同浓度的 staurosporine 3 小时。与未处理的对照相比, staurosporine 浓度增加会伴随着 phospho-MAPKAPK-2 显著减少 (~2.5-fold)。使用 phospho-MAPKAPK-2 测量时,此复合体的 IC50 为 92.5 nM。